NCT01361412View on ClinicalTrials.gov

Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Ragweed Allergy
Interventions
BIOLOGICAL

ToleroMune Ragweed

Intradermal administration 1x8 administrations, 2 weeks apart

BIOLOGICAL

Placebo

Intradermal injection 1x8 administrations, 2 weeks apart

Trial Locations (1)

L4W 1N2

Cetero Research, Mississauga

Sponsors
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

collaborator

Cetero Research, San Antonio

NETWORK

lead

Circassia Limited

INDUSTRY